The most commonly reported side effects are mild injection site reactions, occasional headache, and transient nausea
In naturally aged mouse models (1820 months old), daily oral administration of 5-amino-1mq capsules for 12 consecutive weeks significantly reduced NNMT activity and increased NAD+ levels in various tissues (liver, kidney, adipose tissue), along with markedly elevated expression of SIRT1 and SIRT3 proteins
Several factors affect how often B12 injections are needed: The severity of the initial deficiency The presence of neurological symptoms Underlying health conditions affecting B12 absorption The patients response to initial therapy Ongoing monitoring of serum B12 levels By customizing the injection frequency for each patient, we make B12 therapy more effective
The FDA concern is not just lack of approval
The treatment helped nerves repair themselves, reduced swelling, improved blood flow, and stopped bleeding more effectively